Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Mar;25(3):375–380. doi: 10.1111/j.1365-2125.1988.tb03316.x

Steady-state pharmacokinetics of lithium carbonate in healthy subjects.

R Hunter 1
PMCID: PMC1386362  PMID: 3129009

Abstract

1. The pharmacokinetics of lithium in six healthy volunteers stabilised on lithium were investigated and appropriate pharmacokinetic parameters calculated. 2. The results illustrate important differences in single and multiple dose lithium pharmacokinetics; the implications for minimising lithium-induced renal damage are discussed.

Full text

PDF
375

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amdisen A. Serum level monitoring and clinical pharmacokinetics of lithium. Clin Pharmacokinet. 1977 Mar-Apr;2(2):73–92. doi: 10.2165/00003088-197702020-00001. [DOI] [PubMed] [Google Scholar]
  2. Baastrup P. C., Poulsen J. C., Schou M., Thomsen K., Amdisen A. Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet. 1970 Aug 15;2(7668):326–330. doi: 10.1016/s0140-6736(70)92870-9. [DOI] [PubMed] [Google Scholar]
  3. Bendz H. Kidney function in lithium-treated patients. A literature survey. Acta Psychiatr Scand. 1983 Nov;68(5):303–324. doi: 10.1111/j.1600-0447.1983.tb07012.x. [DOI] [PubMed] [Google Scholar]
  4. Bennie E. H., Manzoor A. K., Scott A. M., Fell G. S. Serum concentrations of lithium after three proprietary preparations of lithium carbonate (Priadel, Phasal and Camcolit). Br J Clin Pharmacol. 1977 Aug;4(4):479–483. doi: 10.1111/j.1365-2125.1977.tb00766.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi: 10.1159/000180580. [DOI] [PubMed] [Google Scholar]
  6. ENGER E., BLEGEN E. M. THE RELATIONSHIP BETWEEN ENDOGENOUS CREATININE CLEARANCE AND SERUM CREATININE IN RENAL FAILURE. Scand J Clin Lab Invest. 1964;16:273–280. doi: 10.1080/00365516409060517. [DOI] [PubMed] [Google Scholar]
  7. Hetmar O., Bolwig T. G., Brun C., Ladefoged J., Larsen S., Rafaelsen O. J. Lithium: long-term effects on the kidney. I. Renal function in retrospect. Acta Psychiatr Scand. 1986 May;73(5):574–581. doi: 10.1111/j.1600-0447.1986.tb02727.x. [DOI] [PubMed] [Google Scholar]
  8. Johnson G. F., Hunt G. E., Lewis J., St George B. Pharmacokinetics of standard (lithicarb) and sustained-release (Priadel) lithium carbonate preparations in patients. Aust N Z J Psychiatry. 1982 Mar;16(1):64–68. doi: 10.3109/00048678209159471. [DOI] [PubMed] [Google Scholar]
  9. Mellerup E. T., Dam H., Wildschödtz G., Rafaelsen O. J. Lithium effects: relation to lithium dose and to plasma peak levels. Acta Psychiatr Scand. 1979 Aug;60(2):177–184. doi: 10.1111/j.1600-0447.1979.tb03586.x. [DOI] [PubMed] [Google Scholar]
  10. Perry P. J., Dunner F. J., Hahn R. L., Tsuang M. T., Berg M. J. Lithium kinetics in single daily dosing. Acta Psychiatr Scand. 1981 Oct;64(4):281–294. doi: 10.1111/j.1600-0447.1981.tb00785.x. [DOI] [PubMed] [Google Scholar]
  11. Plenge P., Mellerup E. T., Bolwig T. G., Brun C., Hetmar O., Ladefoged J., Larsen S., Rafaelsen O. J. Lithium treatment: does the kidney prefer one daily dose instead of two? Acta Psychiatr Scand. 1982 Aug;66(2):121–128. doi: 10.1111/j.1600-0447.1982.tb00920.x. [DOI] [PubMed] [Google Scholar]
  12. Prien R. F., Caffey E. M., Jr, Klett C. J. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry. 1973 Mar;28(3):337–341. doi: 10.1001/archpsyc.1973.01750330035006. [DOI] [PubMed] [Google Scholar]
  13. Schou M., Amdisen A., Thomsen K., Vestergaard P., Hetmar O., Mellerup E. T., Plenge P., Rafaelsen O. J. Lithium treatment regimen and renal water handling: the significance of dosage pattern and tablet type examined through comparison of results from two clinics with different treatment regimens. Psychopharmacology (Berl) 1982;77(4):387–390. doi: 10.1007/BF00432777. [DOI] [PubMed] [Google Scholar]
  14. Shaw D. M., Hewland R., Johnson A. L., Hilary-Jones P., Howlett M. R. Comparison of serum levels of two sustained-release preparations of lithium carbonate. Curr Med Res Opin. 1974;2(2):90–94. doi: 10.1185/03007997409114250. [DOI] [PubMed] [Google Scholar]
  15. Shelley R. K., Silverstone T. Single dose pharmacokinetics of 5 formulations of lithium: a controlled comparison in healthy subjects. Int Clin Psychopharmacol. 1986 Oct;1(4):324–331. doi: 10.1097/00004850-198610000-00007. [DOI] [PubMed] [Google Scholar]
  16. Tyrer S., Hullin R. P., Birch N. J., Goodwin J. C. Absorption of lithium following administration of slow-release and conventional preparations. Psychol Med. 1976 Feb;6(1):51–58. doi: 10.1017/s0033291700007492. [DOI] [PubMed] [Google Scholar]
  17. Waller D. G., Edwards J. G. Investigating renal function during lithium treatment. Psychol Med. 1985 May;15(2):369–375. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES